Literature DB >> 24471651

MoCA-assessed cognitive function and excellent outcome after aneurysmal subarachnoid hemorrhage at 1 year.

G K C Wong1, S W Lam, A Wong, M Lai, D Siu, W S Poon, V Mok.   

Abstract

BACKGROUND AND
PURPOSE: After aneurysmal subarachnoid hemorrhage (aSAH), cognitive impairment, even mild and relatively isolated, can be devastating, especially in working-age persons. The Montreal Cognitive Assessment (MoCA) is accepted as a valid screening tool for mild cognitive impairment due to cerebral ischaemia. Whether MoCA is independently associated with excellent outcome [a score of 0 on the modified Rankin Scale (mRS) or 18/18 on the Lawton Instrumental Activities of Daily Living (IADL) scale] 1 year after aSAH was assessed.
METHODS: Hong Kong Chinese aSAH patients were assessed prospectively by means of the MoCA, Mini-Mental State Examination (MMSE), mRS and IADL scale at 1 year. This multicenter prospective observational study is registered at ClinicalTrials.gov of the US National Institutes of Health (NCT01038193).
RESULTS: In all, 194 patients completed the assessments at 1 year. After adjustment for age, both excellent IADL and mRS outcomes were associated with MoCA (OR 1.2, 95% CI 1.1-1.3, P < 0.001, and OR 1.1, 95% CI 1.0-1.2, P = 0.001, respectively).
CONCLUSIONS: MoCA-assessed cognitive function is an important determinant for excellent outcomes after aSAH.
© 2014 The Author(s) European Journal of Neurology © 2014 EFNS.

Entities:  

Keywords:  Mini-Mental State Examination; Montreal Cognitive Assessment; cerebral aneurysm; cognition; subarachnoid hemorrhage

Mesh:

Year:  2014        PMID: 24471651     DOI: 10.1111/ene.12363

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

1.  Prioritization and Timing of Outcomes and Endpoints After Aneurysmal Subarachnoid Hemorrhage in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group.

Authors:  Martin N Stienen; Johanna M Visser-Meily; Tom A Schweizer; Daniel Hänggi; R Loch Macdonald; Mervyn D I Vergouwen
Journal:  Neurocrit Care       Date:  2019-06       Impact factor: 3.210

2.  A Systematic Review of Cognitive Outcomes in Angiographically Negative Subarachnoid Haemorrhage.

Authors:  Tom Burke; Stephanie Hughes; Alan Carr; Mohsen Javadpour; Niall Pender
Journal:  Neuropsychol Rev       Date:  2018-10-23       Impact factor: 7.444

3.  Severe cognitive impairment in aneurysmal subarachnoid hemorrhage: Predictors and relationship to functional outcome.

Authors:  Joseph R Geraghty; Melissa N Lara-Angulo; Milen Spegar; Jenna Reeh; Fernando D Testai
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-06-20       Impact factor: 2.136

4.  Glucose metabolism measured by positron emission tomography is reduced in patients with white matter presumably ischemic lesions.

Authors:  Jian Li; Wenli Hu
Journal:  Med Sci Monit       Date:  2014-08-27

5.  Psychometric properties of cognitive screening for patients with cerebrovascular diseases A systematic review.

Authors:  Jaqueline de Carvalho Rodrigues; Natália Becker; Carolina Luísa Beckenkamp; Camila Schorr Miná; Jerusa Fumagalli de Salles; Denise Ruschel Bandeira
Journal:  Dement Neuropsychol       Date:  2019 Jan-Mar

6.  Joint associations of smartphone use and gender on multidimensional cognitive health among community-dwelling older adults: a cross-sectional study.

Authors:  Manqiong Yuan; Jia Chen; Zi Zhou; Jiahui Yin; Jielong Wu; Mingliang Luo; Lixia Wang; Ya Fang
Journal:  BMC Geriatr       Date:  2019-05-24       Impact factor: 3.921

7.  Screening tools for early neuropsychological impairment after aneurysmal subarachnoid hemorrhage.

Authors:  Ilari M Rautalin; Martina Sebök; Menno R Germans; Miikka Korja; Noemi Dannecker; Olivia Zindel-Geisseler; Peter Brugger; Luca Regli; Martin N Stienen
Journal:  Neurol Sci       Date:  2019-12-04       Impact factor: 3.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.